CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine

Click For Larger Image & Read More
CEO says AstraZeneca likely to run new global...
 © CyprusMail 2021
AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage, its chief executive was quoted as saying on Thursday amid questions over the results from its late-stage study.

Instead of adding the trial to an ongoing U.S. process, AstraZeneca might launch a fresh study to evaluate a lower dosage of its vaccine that performed better than a full dosage, Pascal Soriot was quoted as saying in a Bloomberg News report.

“Now that we’ve found what looks like a better efficacy we have to validate this, so we need to do an additional...


Read all latest: Cyprus Coronavirus News Updates - Live

This article was automatically added to our system 26-11-2020

CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine


The contents of this article including any associated images are © CyprusMail 2021
Views & opinions expressed in this article are those of the author and/or CyprusMail .

  • Click Here
Advertise Here

  Trending Cyprus News

  • Click Here
Advertise Here

Article Tags: astrazeneca, likely, global, trial, covid, vaccine,